Post-stroke cognitive impairment and dementia

NS Rost, A Brodtmann, MP Pase, SJ van Veluw… - Circulation …, 2022 - Am Heart Assoc
Poststroke cognitive impairment and dementia (PSCID) is a major source of morbidity and
mortality after stroke worldwide. PSCID occurs as a consequence of ischemic stroke …

Cognitive impairment after ischemic and hemorrhagic stroke: a scientific statement from the American Heart Association/American Stroke Association

N El Husseini, IL Katzan, NS Rost, ML Blake, E Byun… - Stroke, 2023 - Am Heart Assoc
Purpose: Cognitive impairment is a common consequence of stroke and has direct
implications for poststroke functioning and quality of life, including the ability to maintain a …

[HTML][HTML] Vascular cognitive impairment (VCI)

T Rundek, M Tolea, T Ariko, EA Fagerli, CJ Camargo - Neurotherapeutics, 2022 - Elsevier
Vascular cognitive impairment (VCI) is predominately caused by vascular risk factors and
cerebrovascular disease. VCI includes a broad spectrum of cognitive disorders, from mild …

European Stroke Organisation and European Academy of Neurology joint guidelines on post-stroke cognitive impairment

TJ Quinn, E Richard, Y Teuschl… - European stroke …, 2021 - journals.sagepub.com
The optimal management of post-stroke cognitive impairment remains controversial. These
joint European Stroke Organisation (ESO) and European Academy of Neurology (EAN) …

Long-term effects of cholinesterase inhibitors on cognitive decline and mortality

H Xu, S Garcia-Ptacek, L Jönsson, A Wimo… - Neurology, 2021 - AAN Enterprises
Objective To investigate whether cholinesterase inhibitors (ChEIs) are associated with
slower cognitive decline in Alzheimer dementia and decreased risk of severe dementia or …

ESO Guideline on covert cerebral small vessel disease

JM Wardlaw, S Debette, H Jokinen… - European Stroke …, 2021 - journals.sagepub.com
'Covert'cerebral small vessel disease (ccSVD) is common on neuroimaging in persons
without overt neurological manifestations, and increases the risk of future stroke, cognitive …

Novel insights into non-alcoholic fatty liver disease and dementia: insulin resistance, hyperammonemia, gut dysbiosis, vascular impairment, and inflammation

SY Cheon, J Song - Cell & Bioscience, 2022 - Springer
Non-alcoholic fatty liver disease (NAFLD) is a metabolic disease characterized by multiple
pathologies. The progression of dementia with NAFLD may be affected by various risk …

Cognitive impairment in older adults: epidemiology, diagnosis, and treatment

NP Palmer, BT Ortega, P Joshi - Psychiatric Clinics, 2022 - psych.theclinics.com
With an increasingly aging population, health care providers will treat a higher number of
patients with cognitive impairment. Identifying cognitive impairment and intervening early …

Aromatherapy for dementia

LT Forrester, N Maayan, M Orrell… - Cochrane Database …, 2014 - cochranelibrary.com
Background Complementary therapy has received great interest within the field of dementia
treatment and the use of aromatherapy and essential oils is increasing. In a growing …

[HTML][HTML] Cerebral small vessel disease–related dementia: more questions than answers

FM Elahi, MM Wang, JF Meschia - Stroke, 2023 - journals.lww.com
Cerebral small vessel disease (CSVD) has emerged as a common factor driving age-
dependent diseases, including stroke and dementia. CSVD-related dementia will affect a …